Table 1.
Demographic and baseline characteristics
| Quinidine | Digoxin | Amiodarone | Verapamil | Atorvastatin | Dronedarone | |
|---|---|---|---|---|---|---|
| Enrolled | 42 | 48 | 30 | 34 | 32 | 34 |
| Completed | 29 | 46 | 28 | 30 | 29 | 31 |
| Sex [N (%)] | ||||||
| Male | 35 (83.3) | 45 (93.8) | 26 (86.7) | 28 (82.4) | 22 (68.8) | 34 (100) |
| Female | 7 (16.7) | 3 (6.3) | 4 (13.3) | 6 (17.6) | 10 (31.3) | 0 |
| Race [N (%)] | ||||||
| American Indian/Alaskan Native | 1 (2.4) | 1 (2.1) | 0 | 0 | 0 | 0 |
| Asian | 1 (2.4) | 1 (2.1) | 1 (3.3) | 0 | 0 | 0 |
| Black/African American | 26 (61.9) | 32 (66.7) | 18 (60.0) | 31 (91.2) | 1 (3.1) | 25 (73.5) |
| Native Hawaiian/Pacific Islander | 0 | 1 (2.1) | 1 (3.3) | 0 | 0 | 1 (2.9) |
| Other | 2 (4.8) | 0 | 0 | 0 | 0 | 1 (2.9) |
| White | 13 (31.0) | 13 (27.1) | 10 (33.3) | 3 (8.8) | 31 (96.9) | 7 (20.6) |
| Age, years [mean (SD)] | 30.9 (7.5) | 31.1 (7.4) | 32.2 (6.4) | 31.4 (8.3) | 24.4 (4.7) | 29.9 (6.7) |
| Weight, kg [mean (SD)] | 79.7 (12.0) | 78.7 (11.7) | 81.7 (11.3) | 79.0 (12.8) | 72.0 (11.9) | 83.2 (9.1) |
SD standard deviation